共 50 条
The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis
被引:18
|作者:
De Matteis, Giovanna
[1
,2
]
Zanotti, Roberta
[2
,3
]
Colarossi, Sabrina
[4
]
De Benedittis, Caterina
[4
]
Garcia-Montero, Andres
[5
,6
,7
]
Bonifacio, Massimiliano
[2
,3
]
Sartori, Marta
[1
]
Aprili, Fiorenza
[1
]
Caruso, Beatrice
[1
]
Paviati, Elisa
[1
]
Carli, Giuseppe
[2
,3
]
Perbellini, Omar
[2
,3
]
Zamo, Alberto
[8
]
Bonadonna, Patrizia
[2
,9
]
Pizzolo, Giovanni
[2
]
Guidi, Giancesare
[1
]
Martinelli, Giovanni
[4
]
Soverini, Simona
[4
]
机构:
[1] Univ Verona, Dept Life & Reprod Sci, Clin Biochem Sect, I-37100 Verona, Italy
[2] Multidisciplinary Outpatients Clin Mastocytosis, Verona, Italy
[3] Univ Verona, Dept Med, Sect Haematol, I-37100 Verona, Italy
[4] Univ Bologna, Dept Haematol & Oncol, Bologna, Italy
[5] Spanish Network Mastocytosis REMA, Salamanca, Spain
[6] Univ Salamanca, Dept Med, Ctr Invest Canc IBMCC USAL CSIC, E-37008 Salamanca, Spain
[7] Univ Salamanca, Serv Gen Citometria, IBSAL, E-37008 Salamanca, Spain
[8] Univ Verona, Sect Pathol Anat, I-37100 Verona, Italy
[9] Azienda Osped Univ Integrata, Allergy Unit, Verona, Italy
关键词:
Systemic mastocytosis;
KIT;
D816V;
Real time PCR;
D-HPLC;
Sequencing;
MAST-CELL DISORDERS;
POLYMERASE-CHAIN-REACTION;
C-KIT;
BONE-MARROW;
CONSENSUS STATEMENTS;
MOLECULAR DIAGNOSIS;
MUTATION ANALYSIS;
DISEASE;
ANAPHYLAXIS;
STANDARDS;
D O I:
10.1016/j.leukres.2014.11.029
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Patients with Systemic Mastocytosis (SM) need a highly sensitive diagnostic test for D816V detection of the KIT receptor gene. Along with histology/cytology and flow cytometry evaluation, bone marrow (BM) from 110 consecutive adult patients referred with a suspicion of SM to Multidisciplinary Outpatient Clinic for Mastocytosis in Verona were tested both by Amplification Refractory Mutation System Reverse Transcriptase quantitative real time Polymerase Chain Reaction (ARMS-RT-qPCR) and RT-PCR + Restriction Fragment Length Polymorphism (RFLP) followed by Denaturing-High Performance Liquid Chromatography (D-HPLC) and Sanger sequencing. ARMS-RT-qPCR identified D816V mutation in 77 patients, corresponding to 100% of cases showing CD25(+) mast cells (MCs) whereas RT-PCR + RFLP/D-HPLC + sequencing revealed D816V mutations in 47 patients. According to the 2008 WHO criteria 75 SM, 1 Cutaneous Mastocytosis (CM), 1 monoclonal MC activation syndrome (MMAS), and 1 SM Associated with Haematologic Non-Mast Cell Disorder (SM-AHNMD) were diagnosed. Seventeen out 75 SM patients (23%) would have not satisfied sufficient WHO criteria on the basis of the sole RT-PCR + RFLP: these patients had significantly lower serum tryptase levels and amount of CD25+ MCs. Therefore, ARMS-RT-qPCR might result particularly useful, in patients that do not fulfil major BM histological criterion, for the recognition of indolent SM with a very low MC burden. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:273 / 278
页数:6
相关论文